Ethema Health Corporation (GRST)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -541.92 Thousand USD | -210.8% |
| 2022 | 489.11 Thousand USD | 77.55% |
| 2021 | 275.47 Thousand USD | 268.65% |
| 2020 | -163.34 Thousand USD | 96.11% |
| 2019 | -4.19 Million USD | -45.61% |
| 2018 | -2.88 Million USD | -98.49% |
| 2017 | -1.45 Million USD | -83.74% |
| 2016 | -790.88 Thousand USD | -146.71% |
| 2015 | -320.57 Thousand USD | 76.1% |
| 2014 | -1.34 Million USD | 17.75% |
| 2013 | -1.63 Million USD | -9.88% |
| 2012 | -1.48 Million USD | 45.39% |
| 2011 | -2.71 Million USD | -680.79% |
| 2010 | -348.11 Thousand USD | -776.45% |
| 2009 | -39.71 Thousand USD | -177.97% |
| 2008 | -14.28 Thousand USD | 83.85% |
| 2007 | -88.5 Thousand USD | -637.5% |
| 2006 | -12 Thousand USD | -20.55% |
| 2005 | -9954.00 USD | 83.83% |
| 2004 | -61.54 Thousand USD | 81.57% |
| 2003 | -333.9 Thousand USD | 0.0% |
| 2001 | 120 Thousand USD | -94.03% |
| 2000 | 2.01 Million USD | -4.29% |
| 1999 | 2.1 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -277.51 Thousand USD | -21.15% |
| 2024 Q1 | -229.07 Thousand USD | 66.44% |
| 2023 Q2 | 32.14 Thousand USD | -57.15% |
| 2023 Q1 | 75.02 Thousand USD | -30.16% |
| 2023 FY | -541.92 Thousand USD | -210.8% |
| 2023 Q4 | -682.62 Thousand USD | -2135.97% |
| 2023 Q3 | 33.52 Thousand USD | 4.3% |
| 2022 Q3 | 254.98 Thousand USD | 392.6% |
| 2022 FY | 489.11 Thousand USD | 77.55% |
| 2022 Q4 | 107.43 Thousand USD | -57.87% |
| 2022 Q2 | 51.76 Thousand USD | -30.93% |
| 2022 Q1 | 74.94 Thousand USD | 133.88% |
| 2021 Q1 | 38.77 Thousand USD | 234.65% |
| 2021 Q4 | -221.18 Thousand USD | -285.92% |
| 2021 FY | 275.47 Thousand USD | 268.65% |
| 2021 Q3 | 118.96 Thousand USD | 81.5% |
| 2021 Q2 | 65.54 Thousand USD | 69.03% |
| 2020 FY | -163.34 Thousand USD | 96.11% |
| 2020 Q4 | -28.79 Thousand USD | -4.92% |
| 2020 Q3 | -27.44 Thousand USD | -66.43% |
| 2020 Q2 | -16.49 Thousand USD | 81.8% |
| 2020 Q1 | -90.6 Thousand USD | 77.33% |
| 2019 Q1 | -1.39 Million USD | -72.22% |
| 2019 Q4 | -399.66 Thousand USD | 60.45% |
| 2019 FY | -4.19 Million USD | -45.61% |
| 2019 Q2 | -1.39 Million USD | -0.05% |
| 2019 Q3 | -1.01 Million USD | 27.57% |
| 2018 Q3 | -927.3 Thousand USD | -27.24% |
| 2018 Q1 | -418.54 Thousand USD | 53.31% |
| 2018 Q2 | -728.77 Thousand USD | -74.12% |
| 2018 Q4 | -809.69 Thousand USD | 12.68% |
| 2018 FY | -2.88 Million USD | -98.49% |
| 2017 Q4 | -896.47 Thousand USD | -1081.57% |
| 2017 FY | -1.45 Million USD | -83.74% |
| 2017 Q3 | 91.33 Thousand USD | 537.43% |
| 2017 Q2 | -20.87 Thousand USD | 96.67% |
| 2017 Q1 | -627.13 Thousand USD | 50.12% |
| 2016 Q2 | 120.68 Thousand USD | -18.36% |
| 2016 FY | -790.88 Thousand USD | -146.71% |
| 2016 Q4 | -1.25 Million USD | -735.58% |
| 2016 Q1 | 147.83 Thousand USD | 154.09% |
| 2016 Q3 | 197.8 Thousand USD | 63.9% |
| 2015 FY | -320.57 Thousand USD | 76.1% |
| 2015 Q2 | 118.59 Thousand USD | 139.0% |
| 2015 Q3 | 138.2 Thousand USD | 16.54% |
| 2015 Q4 | -273.28 Thousand USD | -297.73% |
| 2015 Q1 | -304.08 Thousand USD | 75.58% |
| 2014 Q2 | 110.8 Thousand USD | 117.78% |
| 2014 FY | -1.34 Million USD | 17.75% |
| 2014 Q4 | -1.24 Million USD | -700.19% |
| 2014 Q3 | 207.51 Thousand USD | 87.27% |
| 2014 Q1 | -623.06 Thousand USD | 30.52% |
| 2013 Q4 | -896.74 Thousand USD | -2735.1% |
| 2013 Q3 | -31.63 Thousand USD | 90.97% |
| 2013 FY | -1.63 Million USD | -9.88% |
| 2013 Q1 | -376.13 Thousand USD | -62.35% |
| 2013 Q2 | -350.27 Thousand USD | 6.87% |
| 2012 Q3 | -412.02 Thousand USD | -13.09% |
| 2012 FY | -1.48 Million USD | 45.39% |
| 2012 Q4 | -231.68 Thousand USD | 43.77% |
| 2012 Q1 | 425.76 Thousand USD | 144.8% |
| 2012 Q2 | -364.33 Thousand USD | -185.57% |
| 2011 Q2 | -720.38 Thousand USD | -211.54% |
| 2011 Q4 | -950.33 Thousand USD | -16.45% |
| 2011 Q3 | -816.11 Thousand USD | -13.29% |
| 2011 Q1 | -231.23 Thousand USD | -34.36% |
| 2011 FY | -2.71 Million USD | -680.79% |
| 2010 FY | -348.11 Thousand USD | -776.45% |
| 2010 Q4 | -172.1 Thousand USD | -190.58% |
| 2010 Q3 | -59.22 Thousand USD | 46.61% |
| 2010 Q2 | -110.92 Thousand USD | -1794.57% |
| 2010 Q1 | -5855.00 USD | 65.18% |
| 2009 Q3 | -13.77 Thousand USD | -109.34% |
| 2009 Q4 | -16.81 Thousand USD | -22.04% |
| 2009 Q1 | -2542.00 USD | 67.09% |
| 2009 FY | -39.71 Thousand USD | -177.97% |
| 2009 Q2 | -6582.00 USD | -158.93% |
| 2008 Q1 | -10 Thousand USD | -106.9% |
| 2008 Q3 | -22.52 Thousand USD | 13.34% |
| 2008 Q4 | -7725.00 USD | 65.7% |
| 2008 FY | -14.28 Thousand USD | 83.85% |
| 2008 Q2 | -25.98 Thousand USD | -159.88% |
| 2007 FY | -88.5 Thousand USD | -637.5% |
| 2007 Q3 | -15 Thousand USD | 90.32% |
| 2007 Q2 | -155 Thousand USD | -144.09% |
| 2007 Q1 | -63.5 Thousand USD | -6250.0% |
| 2007 Q4 | 145 Thousand USD | 1066.67% |
| 2006 Q2 | -1000.00 USD | 88.89% |
| 2006 Q1 | -9000.00 USD | -800.9% |
| 2006 FY | -12 Thousand USD | -20.55% |
| 2006 Q3 | -1000.00 USD | 0.0% |
| 2006 Q4 | -1000.00 USD | 0.0% |
| 2005 FY | -9954.00 USD | 83.83% |
| 2005 Q2 | -6722.00 USD | -521.26% |
| 2005 Q3 | -1151.00 USD | 82.88% |
| 2005 Q4 | -999.00 USD | 13.21% |
| 2005 Q1 | -1082.00 USD | 95.32% |
| 2004 Q4 | -23.13 Thousand USD | -164.48% |
| 2004 Q2 | -12.2 Thousand USD | 30.09% |
| 2004 Q3 | -8749.00 USD | 28.3% |
| 2004 Q1 | -17.45 Thousand USD | -256.01% |
| 2004 FY | -61.54 Thousand USD | 81.57% |
| 2003 FY | -333.9 Thousand USD | 0.0% |
| 2003 Q3 | -2000.00 USD | 0.0% |
| 2003 Q1 | -1000.00 USD | 0.0% |
| 2003 Q4 | -4903.00 USD | -145.15% |
| 2001 Q3 | 210 Thousand USD | -12.5% |
| 2001 Q4 | -410 Thousand USD | -295.24% |
| 2001 FY | 120 Thousand USD | -94.03% |
| 2001 Q2 | 240 Thousand USD | 166.67% |
| 2001 Q1 | 90 Thousand USD | -88.31% |
| 2000 FY | 2.01 Million USD | -4.29% |
| 2000 Q2 | 350 Thousand USD | -7.89% |
| 2000 Q3 | 500 Thousand USD | 42.86% |
| 2000 Q4 | 770 Thousand USD | 54.0% |
| 2000 Q1 | 380 Thousand USD | 0.0% |
| 1999 FY | 2.1 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -25.84 Million USD | 97.903% |
| Arem Pacific Corporation | -23.6 Thousand USD | -2196.174% |
| Assisted 4 Living, Inc. | -121.58 Thousand USD | -345.728% |
| BioCorRx Inc. | -3.78 Million USD | 85.693% |
| Bionik Laboratories Corp. | -4.82 Million USD | 88.769% |
| Banyan Corp. | -1.59 Million USD | 66.0% |
| Clearday, Inc. | -11.85 Million USD | 95.428% |
| Dental Patient Care America, Inc. | -31.55 Thousand USD | -1617.274% |
| Quantum Medical Transport, Inc. | 222.84 USD | 243287.938% |
| Empower Clinics Inc. | -4.95 Million USD | 89.062% |
| First Choice Healthcare Solutions, Inc. | -2.41 Million USD | 77.518% |
| Selectis Health, Inc. | -8.96 Million USD | 93.952% |
| HealthLynked Corp. | -3.83 Million USD | 85.857% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 79.584% |
| JRSIS Health Care Corporation | -188.59 Thousand USD | -187.341% |
| Comjoyful International Company | - USD | Infinity% |
| Medical Facilities Corporation | 67.1 Million USD | 100.808% |
| MedSmart Group Inc. | -84.51 Thousand USD | -541.25% |
| North America Frac Sand, Inc. | -702.5 Thousand USD | 22.858% |
| Nova Leap Health Corp. | 460.15 Thousand USD | 217.77% |
| Nexteligent Holdings, Inc. | -201.72 Thousand USD | -168.642% |
| PAO Group, Inc. | -45.42 Thousand USD | -1093.131% |
| Primemd Inc. | 4.15 Million USD | 113.031% |
| Raffles Medical Group Ltd | 87.71 Million USD | 100.618% |
| Ryman Healthcare Limited | -26.98 Million USD | 97.992% |
| Stem Cell Authority, Ltd. | -4230.00 USD | -12711.348% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -2.25 Million USD | 75.923% |
| Mycotopia Therapies, Inc. | -616.72 Thousand USD | 12.129% |
| U.S. NeuroSurgical Holdings, Inc. | -765 Thousand USD | 29.161% |
| Veltex Corporation | -1.08 Million USD | 49.939% |
| World Financial Holding Group | -28.43 Thousand USD | -1806.155% |
| Xcelerate Inc. | -2.61 Million USD | 79.258% |